Mebhydrolin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13808 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 27 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | endolymphatic hydrops | KG + DL |
| 2 | active vestibular Meniere disease | KG + DL |
| 3 | active cochlear Meniere disease | KG + DL |
| 4 | active cochleovestibular Meniere disease | KG + DL |
| 5 | vertigo, benign recurrent, 2 | KG + DL |
| 6 | neuromuscular junction disease | KG + DL |
| 7 | primary hereditary glaucoma | KG + DL |
| 8 | congenital myasthenic syndrome with tubular aggregates | KG + DL |
| 9 | adult-onset myasthenia gravis | KG + DL |
| 10 | open-angle glaucoma | KG + DL |
| 11 | myasthenia, congenital, refractory to acetylcholinesterase inhibitors | KG + DL |
| 12 | myasthenic syndrome, congenital, 24, presynaptic | KG + DL |
| 13 | myasthenic syndrome, congenital, 25, presynaptic | KG + DL |
| 14 | allergic asthma | KG + DL |
| 15 | autoimmune disease of peripheral nervous system | KG + DL |
| 16 | neonatal myasthenia gravis | KG + DL |
| 17 | myasthenia gravis with thymus hyperplasia | KG + DL |
| 18 | disease of receptor activity | KG + DL |
| 19 | intrinsic asthma | KG + DL |
| 20 | myasthenia, limb-girdle, autoimmune | KG + DL |
| 21 | enterocolitis (disease) | KG + DL |
| 22 | short bowel syndrome | KG + DL |
| 23 | hypotrichosis simplex of the scalp | KG + DL |
| 24 | atypical hemolytic-uremic syndrome with B factor anomaly | KG + DL |
| 25 | congenital hypotrichosis milia | KG + DL |
| 26 | Meniere disease | KG + DL |
| 27 | idiopathic bronchiectasis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.